Fortrea Stock Quote FTRE - Stock Price, News, Charts, Message Board, Trades

Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Get Started

Home
Investing
Stocks
USA
NASDAQ
Fortrea Holdings Inc (FTRE) Quote

Fortrea Holdings Inc (FTRE)

18.86

-0.48

(-2.48%)

Closed November 18 4:00PM

Delayed by 15 minutes

18.70

-0.16

(-0.85%)

After Hours: 7:15PM

Delayed by 15 minutes

Empower your portfolio: Real-time discussions and actionable trading ideas.

Current Price

18.70

Bid

18.04

Ask

19.00

Volume

801,435

18.66 Day's Range 19.492

16.53 52 Week Range 41.02

Market Cap

Previous Close

19.34

Open

19.19

Last Trade

Last Trade Time

Financial Volume

$ 15,202,330

VWAP

18.9689

Average Volume (3m)

1,558,864

Shares Outstanding

89,600,000

Dividend Yield

-

PE Ratio

-497.63

Earnings Per Share (EPS)

-0.04

Revenue

3.11B

Net Profit

-3.4M

Fortrea Holdings Inc. provides clinical development and patient access solutions to the life sciences industry. It offers phase I-IV clinical trial management, clinical pharmacology, differentiated technology enabled trial solutions, and post approval services. The company serves pharmaceutical, bio... Fortrea Holdings Inc. provides clinical development and patient access solutions to the life sciences industry. It offers phase I-IV clinical trial management, clinical pharmacology, differentiated technology enabled trial solutions, and post approval services. The company serves pharmaceutical, biotechnology, and medical device organizations. Fortrea Holdings Inc. is based in Durham, North Carolina. Show more

Sector

Medical Laboratories

Industry

Medical Laboratories

Website

www.fortrea.com

Headquarters

Wilmington, Delaware, USA

Founded

-

Fortrea Holdings Inc is listed in the Medical Laboratories sector of the NASDAQ with ticker FTRE. The last closing price for Fortrea was $19.34. Over the last year, Fortrea shares have traded in a share price range of $ 16.53 to $ 41.02.

Fortrea currently has 89,600,000 shares outstanding. The market capitalization of Fortrea is $1.73 billion. Fortrea has a price to earnings ratio (PE ratio) of -497.63.

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 8-K - Current report

Fortrea Reports Third Quarter 2024 Results

For the three months ended September 30, 2024, from continuing operations: Revenues of $674.9 millionGAAP net loss of $(18.5) millionAdjusted EBITDA of $64.2 millionGAAP and adjusted net income...

Fortrea Releases Inaugural Corporate Social Responsibility Report

DURHAM, N.C., Oct. 17, 2024 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE), a leading global contract research organization (CRO), today announced the release of the company’s inaugural Corporate...

Fortrea Announces Date for Third Quarter 2024 Financial Results and Conference Call

DURHAM, N.C., Oct. 14, 2024 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE) (the “Company”), a leading global contract research organization (“CRO”), today announced that it will release its third...

Fortrea Reports Second Quarter 2024 Results

For the three months ended June 30, 2024, from continuing operations: Revenues of $662.4 millionGAAP net loss of $(99.3) millionAdjusted EBITDA of $55.2 millionGAAP and adjusted diluted loss per...

Fortrea Announces Date for Second Quarter 2024 Financial Results and Conference Call

DURHAM, N.C., July 17, 2024 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE) (the “Company”), a leading global contract research organization (CRO), today announced that it will release its second...

Fortrea Appoints Robert Parks as Chief Accounting Officer

DURHAM, N.C., July 11, 2024 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE), a leading global contract research organization (CRO), today announced that Robert “Bobby” Parks has been appointed as...

Fortrea Launches AI Innovation Studio to Galvanize Technology and Human Solutions to Improve Clinical Trial Delivery

DURHAM, N.C., June 27, 2024 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE), a leading global contract research organization (CRO), today announced the launch of its artificial intelligence (AI...

Fortrea to Participate in Virtual Fireside Chat with Evercore ISI

DURHAM, N.C., June 19, 2024 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE), a leading global contract research organization (CRO), today announced that Chief Financial Officer Jill McConnell will...

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 8-K - Current report

Fortrea Reports Third Quarter 2024 Results

For the three months ended September 30, 2024, from continuing operations: Revenues of $674.9 millionGAAP net loss of $(18.5) millionAdjusted EBITDA of $64.2 millionGAAP and adjusted net income...

Fortrea Releases Inaugural Corporate Social Responsibility Report

DURHAM, N.C., Oct. 17, 2024 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE), a leading global contract research organization (CRO), today announced the release of the company’s inaugural Corporate...

Fortrea Announces Date for Third Quarter 2024 Financial Results and Conference Call

DURHAM, N.C., Oct. 14, 2024 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE) (the “Company”), a leading global contract research organization (“CRO”), today announced that it will release its third...

Fortrea Reports Second Quarter 2024 Results

For the three months ended June 30, 2024, from continuing operations: Revenues of $662.4 millionGAAP net loss of $(99.3) millionAdjusted EBITDA of $55.2 millionGAAP and adjusted diluted loss per...

Fortrea Announces Date for Second Quarter 2024 Financial Results and Conference Call

DURHAM, N.C., July 17, 2024 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE) (the “Company”), a leading global contract research organization (CRO), today announced that it will release its second...

Fortrea Appoints Robert Parks as Chief Accounting Officer

DURHAM, N.C., July 11, 2024 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE), a leading global contract research organization (CRO), today announced that Robert “Bobby” Parks has been appointed as...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-5.78	-23.6111111111	24.48	25.28	18.5	1332167	21.1852145	CS
4	-1.15	-5.79345088161	19.85	25.28	16.53	1562532	19.74237909	CS
12	-3.44	-15.5374887082	22.14	25.28	16.53	1558864	20.60992692	CS
26	-8.68	-31.7019722425	27.38	28.41	16.53	1503948	22.59362005	CS
52	-13.04	-41.0838059231	31.74	41.02	16.53	1258941	27.0371267	CS
156	-15.1	-44.674556213	33.8	41.02	16.53	1438831	28.46557685	CS
260	-15.1	-44.674556213	33.8	41.02	16.53	1438831	28.46557685	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
HCWBHCW Biologics Inc	$ 1.235 (319.21%)	511.7M
APLMApollomics Inc	$ 0.1922 (100.42%)	1.68B
SINTSiNtx Technologies Inc	$ 3.18 (55.88%)	52.01M
ACRSAclaris Therapeutics Inc	$ 3.16 (54.15%)	30.65M
JWELJowell Global Ltd	$ 2.8358 (45.43%)	15.45M
QMMMQMMM Holdings Limited	$ 1.73 (-76.40%)	6.14M
CMAXCareMax Inc	$ 0.87 (-48.21%)	838.95k
NGNENeurogene Inc	$ 19.82 (-42.58%)	2M
DWTXDogwood Therapeutics Inc	$ 1.85 (-37.71%)	143.85k
SGDSafe and Green Development Corporation	$ 1.68 (-36.84%)	489.76k
APLMApollomics Inc	$ 0.1922 (100.42%)	1.68B
HCWBHCW Biologics Inc	$ 1.235 (319.21%)	511.7M
ELABElevai Labs Inc	$ 0.0225 (1.81%)	290.23M
NVDANVIDIA Corporation	$ 140.15 (-1.29%)	222.24M
SMCISuper Micro Computer Inc	$ 21.54 (15.93%)	198.08M

crazy horse 0

crazy horse 0 5 minutes ago

Good those idiots should still be held accountable

Pennsylvania Supreme Court Smacks Down Bob Casey, Says Incorrectly Dated Mail Ballots Can’t be Counted

https://www.lifenews.com/2024/11/18/pennsylvania-supreme-court-smacks-down-bob-casey-says-incorrectly-dated-mail-bal

mascale

mascale 7 minutes ago

See Below: (Lots of Veracity(?)!)

NewJerichoMan

NewJerichoMan 8 minutes ago

The FEL-2 (Front-End Loading Phase 2) design phase is a stage in project development that focuses on defining and refining the project's scope, schedule, and cost estimates (feasibility: technically & economically). It's a "decision making gate" before the big time move of FEL-3 (full-on commercial

nwsun

nwsun 9 minutes ago

La de dah. OTC was updated. No change to the os

BZ2

BZ2 9 minutes ago

I wonder why the API supplier hasn't marketed to the other to the companies who are short on API. Could our new API supplier be a Dexcel company/contact?

EternalPatience

EternalPatience 11 minutes ago

As a decade long holder, I don't approve the 1 or 2 year window at all. Delayed is denied. There will be something that creeps in and make it a non starter. This can be a 2025 candidate easily. You have to come out of the DC mindset of, this is too complicated. No it's not..

sekander

sekander 11 minutes ago

head, period. Insert comma.

JoJr

JoJr 11 minutes ago

fink
Am I reading this right that Cohen is going to unify these two companies into one?
AZRH: Definitive Agreement Signed.
ZHUD: Definitive Agreements Signed.

If so, which one will be the dominate one and most explosive, in your opinion?

Gracias.

Makai63

Makai63 12 minutes ago

According to the Orange Book...they are CAPSULEs for all doses.

NY1972

NY1972 12 minutes ago

3 fold increase in dosage leads to 20 fold increase in copies*day/µgDNA.
The potential for FT522 dose-dependent activity was supported by pharmacokinetics (PK), which showed a greater than 20-fold increase in median cumulative PK between the two dose levels (>80,000 copies*day/µgDNA for A-DL2

Krombacher

Krombacher 13 minutes ago

If SSC were the thief in that pilgrim's story, he'd first call the pilgrim a liar and insist that there’s no evidence that thieves even exist. Then he’d deny the existence of the bullet, lecture the pilgrim on proper firearm handling, and insist that muskets are outdated technology with no potential

I ll be back

I ll be back 13 minutes ago

All spot on and "documented" points!

Hamilton Street Associates, LLC have outstanding Real Estate Taxes totaling $361,524.94 on 510 Hamilton Street
Hamilton Street Associates, LLS have outstanding water bills totaling $ 21,679.79 on 510 Hamilton Street
There is no record

blownaccount9

blownaccount9 15 minutes ago

Doesn’t really matter. I think we are capped at around $4-5 until there is definitive news regarding terms of release. We obviously shouldn’t get too far ahead of ourselves when we likely are going to need 1-2 more years until we are fully released and privatized. It’s hard for me to remain patient

fuagf

fuagf 15 minutes ago

conix, A blatant public lie. You know and i know and any able to access the Manage view here would know your

"Ho hum--another example of your censorship when I posted a link. Everybody
here should know that there was a link in this post just deleted"

is a st

TightCoil

TightCoil 15 minutes ago

What's a new head period?

manibiotech

manibiotech 16 minutes ago

Jan 2 2024 - 0.70
Today - 0.275

Best year indeed . It's huge .

Cosa

Cosa 16 minutes ago

All those years of DCA.... Looking great!

jobynimble

jobynimble 18 minutes ago

There’s no red X in Manage mode showing it’s deleted…

lodas

lodas 19 minutes ago

you are trying to hard to make "something out of nothing".... first of all your locution sucks!!!... who is doing what to whom?, for what reason?, who is doing what to who?, you need to take a class in english composition...are you the one with the BS in Finance?... how do you engage in my posts, an

imbellish

imbellish 19 minutes ago

Precisely I think why we haven't heard of any potential appoints

EternalPatience

EternalPatience 19 minutes ago

I won't complain but I think they need something there until this cship is resolved

JJ8

JJ8 20 minutes ago

Nvidia share price pattern remains in Double Top Breakdown mode since 15-Nov-2024. BLTA

JamesF1

JamesF1 20 minutes ago

There are two different products, Vyvanse capsules and Vyvanse chewable tablets . The capsules are way more commonly prescribed . My assumption is that Elite’s product is the capsules, but it’s a good question to ask. Perhaps Elite will make both?

carlson

carlson 22 minutes ago

I kept thinking there was going to be profit taking today. Great GAIN today on NEWS. Some people don't get it yet but they will REGRET. There's no telling how high NBRI will RUN TO...

Stinger2014

Stinger2014 23 minutes ago

MMs will continue to shake us with manipulation.

Delayed Upgrade Clock

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions